278 related articles for article (PubMed ID: 34489937)
1. Interpreting Immunoregulation in Lung Fibrosis: A New Branch of the Immune Model.
Huaux F
Front Immunol; 2021; 12():690375. PubMed ID: 34489937
[TBL] [Abstract][Full Text] [Related]
2. Emerging Role of Immunosuppression in Diseases Induced by Micro- and Nano-Particles: Time to Revisit the Exclusive Inflammatory Scenario.
Huaux F
Front Immunol; 2018; 9():2364. PubMed ID: 30510551
[TBL] [Abstract][Full Text] [Related]
3. CCR2
Lebrun A; Lo Re S; Chantry M; Izquierdo Carerra X; Uwambayinema F; Ricci D; Devosse R; Ibouraadaten S; Brombin L; Palmai-Pallag M; Yakoub Y; Pasparakis M; Lison D; Huaux F
J Pathol; 2017 Nov; 243(3):320-330. PubMed ID: 28799208
[TBL] [Abstract][Full Text] [Related]
4. Polarization of Immune Cells in the Pathologic Response to Inhaled Particulates.
Ma Q
Front Immunol; 2020; 11():1060. PubMed ID: 32625201
[TBL] [Abstract][Full Text] [Related]
5. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
6. Sequential expression of IGF-IB followed by active TGF-β1 induces synergistic pulmonary fibroproliferation in vivo.
Andonegui G; Ni A; Léger C; Kelly MM; Wong JF; Jalloul A; Winston BW
Am J Physiol Lung Cell Mol Physiol; 2012 Nov; 303(9):L788-98. PubMed ID: 22923639
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis.
Lo Re S; Lecocq M; Uwambayinema F; Yakoub Y; Delos M; Demoulin JB; Lucas S; Sparwasser T; Renauld JC; Lison D; Huaux F
Am J Respir Crit Care Med; 2011 Dec; 184(11):1270-81. PubMed ID: 21868503
[TBL] [Abstract][Full Text] [Related]
8. In vivo activation of a T helper 2-driven innate immune response in lung fibrosis induced by multi-walled carbon nanotubes.
Dong J; Ma Q
Arch Toxicol; 2016 Sep; 90(9):2231-2248. PubMed ID: 27106021
[TBL] [Abstract][Full Text] [Related]
9. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
[TBL] [Abstract][Full Text] [Related]
10. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
[TBL] [Abstract][Full Text] [Related]
11. Uncoupling between inflammatory and fibrotic responses to silica: evidence from MyD88 knockout mice.
Re SL; Giordano G; Yakoub Y; Devosse R; Uwambayinema F; Couillin I; Ryffel B; Marbaix E; Lison D; Huaux F
PLoS One; 2014; 9(7):e99383. PubMed ID: 25050810
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of lung fibrosis induced by carbon nanotubes: towards an Adverse Outcome Pathway (AOP).
Vietti G; Lison D; van den Brule S
Part Fibre Toxicol; 2016 Feb; 13():11. PubMed ID: 26926090
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
Ostrand-Rosenberg S; Fenselau C
J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
[TBL] [Abstract][Full Text] [Related]
14. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis.
Huaux F; Liu T; McGarry B; Ullenbruch M; Xing Z; Phan SH
J Immunol; 2003 Nov; 171(10):5470-81. PubMed ID: 14607953
[TBL] [Abstract][Full Text] [Related]
15. Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis.
Cicko S; Grimm M; Ayata K; Beckert J; Meyer A; Hossfeld M; Zissel G; Idzko M; Müller T
Respir Res; 2015 Sep; 16(1):105. PubMed ID: 26369416
[TBL] [Abstract][Full Text] [Related]
16. IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis.
Lo Re S; Dumoutier L; Couillin I; Van Vyve C; Yakoub Y; Uwambayinema F; Marien B; van den Brûle S; Van Snick J; Uyttenhove C; Ryffel B; Renauld JC; Lison D; Huaux F
J Immunol; 2010 Jun; 184(11):6367-77. PubMed ID: 20421647
[TBL] [Abstract][Full Text] [Related]
17. Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis.
Damazo AS; Sampaio AL; Nakata CM; Flower RJ; Perretti M; Oliani SM
BMC Immunol; 2011 Oct; 12():59. PubMed ID: 22011168
[TBL] [Abstract][Full Text] [Related]
18. [A new pathologic pathway for pulmonary fibrosis induced by silica: involvement of immunosuppressive responses].
Huaux F
Bull Mem Acad R Med Belg; 2009; 164(5-6):240-6. PubMed ID: 20666153
[TBL] [Abstract][Full Text] [Related]
19. A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis.
Teder P; Noble PW
Am J Respir Cell Mol Biol; 2000 Jul; 23(1):7-10. PubMed ID: 10873147
[No Abstract] [Full Text] [Related]
20. Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.
Liu M; Zeng X; Wang J; Fu Z; Wang J; Liu M; Ren D; Yu B; Zheng L; Hu X; Shi W; Xu J
Stem Cell Res Ther; 2016 Apr; 7(1):63. PubMed ID: 27107963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
